Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

The study recently published in the JAMA Health Forum looked at 16.7 million adults from 2013-2023 between 25-75 years old.

Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...

Despite their remarkable efficacy for many populations, GLP-1s have a relatively low persistence rate over time, due to a ...